Principal Investigators


KU Leuven, Faculteit Geneeskunde, Dept Maatschappelijke Gezondheidszorg en Eerstelijnszorg, Interfacultair Centrum Biomedische Ethiek en Recht

Institution


KU Leuven

Contact information of lead PI


Country


Belgium

Title of project or programme


Biomarker based adaptive development in Alzheimer disease (BioAdaptAD)

Source of funding information


Flanders Innovation & Entrepreneurship

Total sum awarded (Euro)


€ 279,000

Start date of award


01/06/2013

Total duration of award in years


4.0

The project/programme is most relevant to:


Alzheimer's disease & other dementias

Keywords


Research Abstract


The general objectives of this project are to develop a BACE inhibitor for disease modification in Alzheimer’s disease and to explore the development in an earlier prodromal Alzheimer’s disease population. From a drug development perspective, this will involve multiple adaptation steps and the intensive use of biomarkers.

Lay Summary


Further information available at:

Export as PDF